Table 1.
Group A, laparoscopic (n = 34) | Group B, robotic (n = 25) | Group C, vaginal (n = 11) | P | |
---|---|---|---|---|
Age | 0.2101 | |||
N | 34 | 25 | 11 | |
Mean (SD) | 42.5 (8.78) | 46.6 (7.54) | 44.1 (10.72) | |
95% CI | (39.4, 45.5) | (43.5, 49.7) | (36.9, 51.3) | |
Range | (27, 60) | (30, 64) | (32, 63) | |
| ||||
Body mass index | 0.2925 | |||
More than 30 | 20 (58.82%) | 16 (64.00%) | 4 (36.36%) | |
Less than 30 | 14 (41.18%) | 9 (36.00%) | 7 (63.64%) | |
| ||||
Uterine weight (g) | 0.0043 | |||
Less than 250 g | 29 (85.29%) | 14 (56.00%) | 11 (100%) | |
More than 250 g | 5 (14.71%) | 11 (44.00%) | ||
| ||||
Race | 0.1534 | |||
African American | 7 (20.59%) | 12 (48.00%) | 2 (18.18%) | |
White | 21 (61.76%) | 10 (40.00%) | 8 (72.73%) | |
Hispanic | 6 (17.65%) | 3 (12.00%) | 1 (9.09%) | |
| ||||
Prior pelvic or abdominal surgery | 0.3523 | |||
None | 8 (23.53%) | 6 (24.00%) | 6 (54.55%) | |
1 occurrence | 14 (41.18%) | 11 (44.00%) | 3 (27.27%) | |
2 and more occurrences | 12 (35.29%) | 8 (32.00%) | 2 (18.18%) | |
| ||||
Type of surgery | <.0001 | |||
1 | 31 (91.18%) | 21 (84.00%) | 3 (27.27%) | |
2 and more | 3 (8.82%) | 4 (16.00%) | 8 (72.73%) | |
| ||||
Indication for surgery | ||||
Adnexal mass | 3 | 7 | 0 | |
Endometriosis | 2 | 1 | 0 | |
Abnormal uterine bleeding | 9 | 3 | 0 | |
Hyperplasia | 1 | 0 | 0 | |
Dysplasia | 13 | 1 | 3 | |
Leiomyomas | 10 | 11 | 0 | |
SUI | 2 | 2 | 4 | |
Chronic pelvic pain | 3 | 1 | 0 | |
Adenomyosis | 2 | 10 | 1 | |
Pelvic prolapse | 0 | 0 | 7 | |
Other | 2 | 6 | 3 |